Combating atherosclerosis with LXR alpha and PPAR alpha agonists: is rational multitargeted polypharmacy the future of therapeutics in complex diseases?
(Q40477172)
scientific article
scientific article
Language:
Current Data About
Combating atherosclerosis with LXR alpha and PPAR alpha agonists: is rational multitargeted polypharmacy the future of therapeutics in complex diseases?
| (P31) |
(Q13442814)
|
||||||||||
| (P50) |
(Q5543096)
|
||||||||||
| (P304) |
254-257
|
||||||||||
| (P407) |
(Q1860)
|
||||||||||
| (P433) |
5
|
||||||||||
| (P478) |
4
|
||||||||||
| (P577) |
Friday, October 1, 2004
|
||||||||||
| (P921) |
(Q12252367)
|
||||||||||
| (P1433) |
(Q15756221)
|
||||||||||
| (P1476) |
"Combating atherosclerosis with LXR alpha and PPAR alpha agonists: is rational multitargeted polypharmacy the future of therapeutics in complex diseases?" (language: en)
|
||||||||||
| (P2093) |
Tomoshige Kino
|
other details